Skip to main content
Erschienen in: European Archives of Oto-Rhino-Laryngology 2/2018

28.11.2017 | Head and Neck

Significant association of the cytokine variants with head and neck cancer risk: evidence from meta-analysis

verfasst von: Ting-Ting Xiao, Xian Li, Ying Xu, Yong Li

Erschienen in: European Archives of Oto-Rhino-Laryngology | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Abstract

Aim

To evaluate the possible relevance of the IL-18-137 G>C (rs187238), IL-18-607 C>A (rs1946518) and IL-4-590 C>T (rs2243250) polymorphisms to the genetic susceptibility of head and neck cancer.

Methods

Data were retrieved from PubMed, EMBASE, Web of Science and CNKI databases, and the results were independently analysed by two reviewers using Stata 14.0 software.

Results

After searching for and assessing the literature, a total of thirteen studies involving 2,959 patients newly diagnosed as head and neck cancer and 3,622 controls from healthy donors were analysed. The results suggested that a strong relationship between patients and healthy controls was observed in the IL-18-137 G>C polymorphism in consistence with the result (CC vs. GG + GC: OR = 1.63, P = 0.004; CC vs. GG: OR = 1.82, P = 0.001). When stratified by cancer type, ethnicity and the source of control samples, significant and elevated risks were obtained in the genetic susceptibility to Asian patients with NPC in all genetic models and in those studies using the PCR-RFLP test method. In addition, comparable results were obtained for the IL-18-607 C>A polymorphism, especially for Asian patients with NPC.

Conclusions

It should be a potential association between IL-18 variants and nasopharyngeal carcinoma. Furthermore, IL-18 gene variants might be considered as a critical role in predicting the occurrence of nasopharyngeal carcinoma in Asian population. However, the IL-4-590 C>T polymorphism does not influence the development of head and neck cancer.
Literatur
1.
Zurück zum Zitat Argiris A, Karamouzis MV, Raben D, Ferris RL (2008) Head and neck cancer. Lancet 371:1695–1709CrossRefPubMed Argiris A, Karamouzis MV, Raben D, Ferris RL (2008) Head and neck cancer. Lancet 371:1695–1709CrossRefPubMed
2.
Zurück zum Zitat Warnakulasuriya S (2009) Global epidemiology of oral and oropharyngeal cancer. Oral Oncol 45:309–316CrossRefPubMed Warnakulasuriya S (2009) Global epidemiology of oral and oropharyngeal cancer. Oral Oncol 45:309–316CrossRefPubMed
3.
Zurück zum Zitat Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M et al (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359–E386CrossRefPubMed Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M et al (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359–E386CrossRefPubMed
4.
Zurück zum Zitat Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin 65:87–108CrossRefPubMed Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin 65:87–108CrossRefPubMed
5.
Zurück zum Zitat Pai SI, Westra WH (2009) Molecular pathology of head and neck cancer: implications for diagnosis, prognosis, and treatment. Annu Rev Pathol 4:49–70CrossRefPubMedPubMedCentral Pai SI, Westra WH (2009) Molecular pathology of head and neck cancer: implications for diagnosis, prognosis, and treatment. Annu Rev Pathol 4:49–70CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Saba NF, Goodman M, Ward K, Flowers C, Ramalingam S, Owonikoko T et al (2011) Gender and ethnic disparities in incidence and survival of squamous cell carcinoma of the oral tongue, base of tongue, and tonsils: a surveillance, epidemiology and end results program-based analysis. Oncology 81:12–20CrossRefPubMedPubMedCentral Saba NF, Goodman M, Ward K, Flowers C, Ramalingam S, Owonikoko T et al (2011) Gender and ethnic disparities in incidence and survival of squamous cell carcinoma of the oral tongue, base of tongue, and tonsils: a surveillance, epidemiology and end results program-based analysis. Oncology 81:12–20CrossRefPubMedPubMedCentral
7.
8.
Zurück zum Zitat Bell RB, Kademani D, Homer L, Dierks EJ, Potter BE (2007) Tongue cancer: Is there a difference in survival compared with other subsites in the oral cavity? J Oral Maxillofac Surg 65:229–236CrossRefPubMed Bell RB, Kademani D, Homer L, Dierks EJ, Potter BE (2007) Tongue cancer: Is there a difference in survival compared with other subsites in the oral cavity? J Oral Maxillofac Surg 65:229–236CrossRefPubMed
9.
Zurück zum Zitat Alnuaimi AD, Wiesenfeld D, O’Brien-Simpson NM, Reynolds EC, McCullough MJ (2015) Oral Candida colonization in oral cancer patients and its relationship with traditional risk factors of oral cancer: a matched case-control study. Oral Oncol 51:139–145CrossRefPubMed Alnuaimi AD, Wiesenfeld D, O’Brien-Simpson NM, Reynolds EC, McCullough MJ (2015) Oral Candida colonization in oral cancer patients and its relationship with traditional risk factors of oral cancer: a matched case-control study. Oral Oncol 51:139–145CrossRefPubMed
10.
Zurück zum Zitat Gupta B, Johnson NW (2014) Systematic review and meta-analysis of association of smokeless tobacco and of betel quid without tobacco with incidence of oral cancer in South Asia and the Pacific. PLoS One 9:e113385CrossRefPubMedPubMedCentral Gupta B, Johnson NW (2014) Systematic review and meta-analysis of association of smokeless tobacco and of betel quid without tobacco with incidence of oral cancer in South Asia and the Pacific. PLoS One 9:e113385CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Young D, Xiao CC, Murphy B, Moore M, Fakhry C, Day TA (2015) Increase in head and neck cancer in younger patients due to human papillomavirus (HPV). Oral Oncol 51:727–730CrossRefPubMed Young D, Xiao CC, Murphy B, Moore M, Fakhry C, Day TA (2015) Increase in head and neck cancer in younger patients due to human papillomavirus (HPV). Oral Oncol 51:727–730CrossRefPubMed
12.
Zurück zum Zitat Jewett A, Head C, Cacalano NA (2006) Emerging mechanisms of immunosuppression in oral cancers. J Dent Res 85:1061–1073CrossRefPubMed Jewett A, Head C, Cacalano NA (2006) Emerging mechanisms of immunosuppression in oral cancers. J Dent Res 85:1061–1073CrossRefPubMed
13.
Zurück zum Zitat Lalla RV, Tanzer ML, Kreutzer DL (2003) Identification of a region of the fibrin molecule involved in upregulation of interleukin-8 expression from human oral squamous cell carcinoma cells. Arch Oral Biol 48:263–271CrossRefPubMed Lalla RV, Tanzer ML, Kreutzer DL (2003) Identification of a region of the fibrin molecule involved in upregulation of interleukin-8 expression from human oral squamous cell carcinoma cells. Arch Oral Biol 48:263–271CrossRefPubMed
14.
Zurück zum Zitat Min R, Zun Z, Siyi L, Wenjun Y, Lizheng W, Chenping Z (2011) Increased expression of Toll-like receptor-9 has close relation with tumour cell proliferation in oral squamous cell carcinoma. Arch Oral Biol 56:877–884CrossRefPubMed Min R, Zun Z, Siyi L, Wenjun Y, Lizheng W, Chenping Z (2011) Increased expression of Toll-like receptor-9 has close relation with tumour cell proliferation in oral squamous cell carcinoma. Arch Oral Biol 56:877–884CrossRefPubMed
15.
Zurück zum Zitat Wei H, Hongya P, Linlin J, Mujiang A, Kuijie W, Duohong Z et al (2011) IFN-gamma enhances the anti-tumour immune response of dendritic cells against oral squamous cell carcinoma. Arch Oral Biol 56:891–898CrossRefPubMed Wei H, Hongya P, Linlin J, Mujiang A, Kuijie W, Duohong Z et al (2011) IFN-gamma enhances the anti-tumour immune response of dendritic cells against oral squamous cell carcinoma. Arch Oral Biol 56:891–898CrossRefPubMed
16.
Zurück zum Zitat Young MR, Wright MA, Lozano Y, Matthews JP, Benefield J, Prechel MM (1996) Mechanisms of immune suppression in patients with head and neck cancer: influence on the immune infiltrate of the cancer. Int J Cancer 67:333–338CrossRefPubMed Young MR, Wright MA, Lozano Y, Matthews JP, Benefield J, Prechel MM (1996) Mechanisms of immune suppression in patients with head and neck cancer: influence on the immune infiltrate of the cancer. Int J Cancer 67:333–338CrossRefPubMed
17.
Zurück zum Zitat Giedraitis V, He B, Huang WX, Hillert J (2001) Cloning and mutation analysis of the human IL-18 promoter: a possible role of polymorphisms in expression regulation. J Neuroimmunol 112:146–152CrossRefPubMed Giedraitis V, He B, Huang WX, Hillert J (2001) Cloning and mutation analysis of the human IL-18 promoter: a possible role of polymorphisms in expression regulation. J Neuroimmunol 112:146–152CrossRefPubMed
18.
Zurück zum Zitat Wei YS, Lan Y, Liu YG, Tang H, Tang RG, Wang JC (2007) Interleukin-18 gene promoter polymorphisms and the risk of esophageal squamous cell carcinoma. Acta Oncol 46:1090–1096CrossRefPubMed Wei YS, Lan Y, Liu YG, Tang H, Tang RG, Wang JC (2007) Interleukin-18 gene promoter polymorphisms and the risk of esophageal squamous cell carcinoma. Acta Oncol 46:1090–1096CrossRefPubMed
19.
Zurück zum Zitat Myers JN, Yasumura S, Suminami Y, Hirabayashi H, Lin W, Johnson JT et al (1996) Growth stimulation of human head and neck squamous cell carcinoma cell lines by interleukin 4. Clin Cancer Res 2:127–135PubMed Myers JN, Yasumura S, Suminami Y, Hirabayashi H, Lin W, Johnson JT et al (1996) Growth stimulation of human head and neck squamous cell carcinoma cell lines by interleukin 4. Clin Cancer Res 2:127–135PubMed
20.
Zurück zum Zitat Olver S, Apte S, Baz A, Kienzle N (2007) The duplicitous effects of interleukin 4 on tumour immunity: how can the same cytokine improve or impair control of tumour growth? Tissue Antigens 69:293–298CrossRefPubMed Olver S, Apte S, Baz A, Kienzle N (2007) The duplicitous effects of interleukin 4 on tumour immunity: how can the same cytokine improve or impair control of tumour growth? Tissue Antigens 69:293–298CrossRefPubMed
21.
Zurück zum Zitat Toi M, Bicknell R, Harris AL (1992) Inhibition of colon and breast carcinoma cell growth by interleukin-4. Cancer Res 52:275–279PubMed Toi M, Bicknell R, Harris AL (1992) Inhibition of colon and breast carcinoma cell growth by interleukin-4. Cancer Res 52:275–279PubMed
22.
Zurück zum Zitat Le Beau MM, Lemons RS, Espinosa R 3rd, Larson RA, Arai N, Rowley JD (1989) Interleukin-4 and interleukin-5 map to human chromosome 5 in a region encoding growth factors and receptors and are deleted in myeloid leukemias with a del(5q). Blood 73:647–650PubMed Le Beau MM, Lemons RS, Espinosa R 3rd, Larson RA, Arai N, Rowley JD (1989) Interleukin-4 and interleukin-5 map to human chromosome 5 in a region encoding growth factors and receptors and are deleted in myeloid leukemias with a del(5q). Blood 73:647–650PubMed
23.
Zurück zum Zitat Agarwal A, Rani M, Saha GK, Valarmathi TM, Bahadur S, Mohanti BK et al (2003) Disregulated expression of the Th2 cytokine gene in patients with intraoral squamous cell carcinoma. Immunol Invest 32:17–30CrossRefPubMed Agarwal A, Rani M, Saha GK, Valarmathi TM, Bahadur S, Mohanti BK et al (2003) Disregulated expression of the Th2 cytokine gene in patients with intraoral squamous cell carcinoma. Immunol Invest 32:17–30CrossRefPubMed
24.
Zurück zum Zitat Lissoni P, Brivio F, Rovelli F, Fumagalli G, Malugani F, Vaghi M et al (2000) Serum concentrations of interleukin-18 in early and advanced cancer patients: enhanced secretion in metastatic disease. J Biol Regul Homeost Agents 14:275–277PubMed Lissoni P, Brivio F, Rovelli F, Fumagalli G, Malugani F, Vaghi M et al (2000) Serum concentrations of interleukin-18 in early and advanced cancer patients: enhanced secretion in metastatic disease. J Biol Regul Homeost Agents 14:275–277PubMed
25.
Zurück zum Zitat Ye ZB, Ma T, Li H, Jin XL, Xu HM (2007) Expression and significance of intratumoral interleukin-12 and interleukin-18 in human gastric carcinoma. World J Gastroenterol 13:1747–1751CrossRefPubMedPubMedCentral Ye ZB, Ma T, Li H, Jin XL, Xu HM (2007) Expression and significance of intratumoral interleukin-12 and interleukin-18 in human gastric carcinoma. World J Gastroenterol 13:1747–1751CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Huedo-Medina TB, Sanchez-Meca J, Marin-Martinez F, Botella J (2006) Assessing heterogeneity in meta-analysis: Q statistic or I2 index? Psychol Methods 11:193–206CrossRefPubMed Huedo-Medina TB, Sanchez-Meca J, Marin-Martinez F, Botella J (2006) Assessing heterogeneity in meta-analysis: Q statistic or I2 index? Psychol Methods 11:193–206CrossRefPubMed
27.
Zurück zum Zitat Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719–748PubMed Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719–748PubMed
28.
Zurück zum Zitat Curtin F (2017) Meta-analysis combining parallel and cross-over trials with random effects. Res Synth Methods 8:263–274CrossRefPubMed Curtin F (2017) Meta-analysis combining parallel and cross-over trials with random effects. Res Synth Methods 8:263–274CrossRefPubMed
29.
Zurück zum Zitat DuBing ZJ, WeiYE-Sheng (2012) Interleukin-18 gene genetic polymorphisms and risk of nasopharyngeal carcinomar in Han population from Sichuan China. Med J West China 24(9) DuBing ZJ, WeiYE-Sheng (2012) Interleukin-18 gene genetic polymorphisms and risk of nasopharyngeal carcinomar in Han population from Sichuan China. Med J West China 24(9)
30.
Zurück zum Zitat Nong LG, Luo B, Zhang L, Nong HB. Interleukin-18 gene promoter polymorphism and the risk of nasopharyngeal carcinoma in a Chinese population Nong LG, Luo B, Zhang L, Nong HB. Interleukin-18 gene promoter polymorphism and the risk of nasopharyngeal carcinoma in a Chinese population
31.
Zurück zum Zitat Asefi V, Mojtahedi Z, Khademi B, Naeimi S, Ghaderi A (2009) Head and neck squamous cell carcinoma is not associated with interleukin-18 promoter gene polymorphisms: a case-control study. J Laryngol Otol 123:444–448CrossRefPubMed Asefi V, Mojtahedi Z, Khademi B, Naeimi S, Ghaderi A (2009) Head and neck squamous cell carcinoma is not associated with interleukin-18 promoter gene polymorphisms: a case-control study. J Laryngol Otol 123:444–448CrossRefPubMed
32.
Zurück zum Zitat Farhat K, Hassen E, Bouzgarrou N, Gabbouj S, Bouaouina N, Chouchane L (2008) Functional IL-18 promoter gene polymorphisms in Tunisian nasopharyngeal carcinoma patients. Cytokine 43:132–137CrossRefPubMed Farhat K, Hassen E, Bouzgarrou N, Gabbouj S, Bouaouina N, Chouchane L (2008) Functional IL-18 promoter gene polymorphisms in Tunisian nasopharyngeal carcinoma patients. Cytokine 43:132–137CrossRefPubMed
33.
Zurück zum Zitat Lina PGLBTYL (2013) Research on interleukin-18 gene promoter polymorphisms and genetic susceptibility of nasopharyngeal carcinoma. Laboratory Medicine, June 2013, vol 28, no 6 Lina PGLBTYL (2013) Research on interleukin-18 gene promoter polymorphisms and genetic susceptibility of nasopharyngeal carcinoma. Laboratory Medicine, June 2013, vol 28, no 6
34.
Zurück zum Zitat Pratesi C, Bortolin MT, Bidoli E, Tedeschi R, Vaccher E, Dolcetti R et al (2006) Interleukin-10 and interleukin-18 promoter polymorphisms in an Italian cohort of patients with undifferentiated carcinoma of nasopharyngeal type. Cancer Immunol Immunother 55:23–30CrossRefPubMed Pratesi C, Bortolin MT, Bidoli E, Tedeschi R, Vaccher E, Dolcetti R et al (2006) Interleukin-10 and interleukin-18 promoter polymorphisms in an Italian cohort of patients with undifferentiated carcinoma of nasopharyngeal type. Cancer Immunol Immunother 55:23–30CrossRefPubMed
35.
Zurück zum Zitat Singh PK, Ahmad MK, Kumar V, Hussain SR, Gupta R, Jain A et al (2014) Effects of interleukin-18 promoter (C607A and G137C) gene polymorphisms and their association with oral squamous cell carcinoma (OSCC) in northern India. Tumour Biol 35:12275–12284CrossRefPubMed Singh PK, Ahmad MK, Kumar V, Hussain SR, Gupta R, Jain A et al (2014) Effects of interleukin-18 promoter (C607A and G137C) gene polymorphisms and their association with oral squamous cell carcinoma (OSCC) in northern India. Tumour Biol 35:12275–12284CrossRefPubMed
36.
Zurück zum Zitat Tsai HT, Hsin CH, Hsieh YH, Tang CH, Yang SF, Lin CW et al (2013) Impact of interleukin-18 polymorphisms -607A/C and -137G/C on oral cancer occurrence and clinical progression. PLoS One 8:e83572CrossRefPubMedPubMedCentral Tsai HT, Hsin CH, Hsieh YH, Tang CH, Yang SF, Lin CW et al (2013) Impact of interleukin-18 polymorphisms -607A/C and -137G/C on oral cancer occurrence and clinical progression. PLoS One 8:e83572CrossRefPubMedPubMedCentral
37.
Zurück zum Zitat Vairaktaris E, Serefoglou ZC, Yapijakis C, Agapi C, Vassiliou S, Nkenke E et al (2007) The interleukin-18-607A/C polymorphism is not associated with risk for oral cancer. Anticancer Res 27:4011–4014PubMed Vairaktaris E, Serefoglou ZC, Yapijakis C, Agapi C, Vassiliou S, Nkenke E et al (2007) The interleukin-18-607A/C polymorphism is not associated with risk for oral cancer. Anticancer Res 27:4011–4014PubMed
38.
Zurück zum Zitat Gaur P, Mittal M, Mohanti B, Das S (2011) Functional variants of IL4 and IL6 genes and risk of tobacco-related oral carcinoma in high-risk Asian Indians. Oral Dis 17:720–726CrossRefPubMed Gaur P, Mittal M, Mohanti B, Das S (2011) Functional variants of IL4 and IL6 genes and risk of tobacco-related oral carcinoma in high-risk Asian Indians. Oral Dis 17:720–726CrossRefPubMed
39.
Zurück zum Zitat Tsai MH, Chen WC, Tsai CH, Hang LW, Tsai FJ (2005) Interleukin-4 gene, but not the interleukin-1 beta gene polymorphism, is associated with oral cancer. J Clin Lab Anal 19:93–98CrossRefPubMed Tsai MH, Chen WC, Tsai CH, Hang LW, Tsai FJ (2005) Interleukin-4 gene, but not the interleukin-1 beta gene polymorphism, is associated with oral cancer. J Clin Lab Anal 19:93–98CrossRefPubMed
40.
Zurück zum Zitat Vairaktaris E, Yapijakis C, Serefoglou Z, Avgoustidis D, Critselis E, Spyridonidou S et al (2008) Gene expression polymorphisms of interleukins-1 beta, -4, -6, -8, -10, and tumor necrosis factors-alpha, -beta: regression analysis of their effect upon oral squamous cell carcinoma. J Cancer Res Clin Oncol 134:821–832CrossRefPubMed Vairaktaris E, Yapijakis C, Serefoglou Z, Avgoustidis D, Critselis E, Spyridonidou S et al (2008) Gene expression polymorphisms of interleukins-1 beta, -4, -6, -8, -10, and tumor necrosis factors-alpha, -beta: regression analysis of their effect upon oral squamous cell carcinoma. J Cancer Res Clin Oncol 134:821–832CrossRefPubMed
41.
Zurück zum Zitat Yang CM, Chen HC, Hou YY, Lee MC, Liou HH, Huang SJ et al (2014) A high IL-4 production diplotype is associated with an increased risk but better prognosis of oral and pharyngeal carcinomas. Arch Oral Biol 59:35–46CrossRefPubMed Yang CM, Chen HC, Hou YY, Lee MC, Liou HH, Huang SJ et al (2014) A high IL-4 production diplotype is associated with an increased risk but better prognosis of oral and pharyngeal carcinomas. Arch Oral Biol 59:35–46CrossRefPubMed
42.
Zurück zum Zitat Riedel F, Adam S, Feick P, Haas S, Gotte K, Hormann K et al (2004) Expression of IL-18 in patients with head and neck squamous cell carcinoma. Int J Mol Med 13:267–272PubMed Riedel F, Adam S, Feick P, Haas S, Gotte K, Hormann K et al (2004) Expression of IL-18 in patients with head and neck squamous cell carcinoma. Int J Mol Med 13:267–272PubMed
43.
Zurück zum Zitat Obiri NI, Siegel JP, Varricchio F, Puri RK (1994) Expression of high-affinity IL-4 receptors on human melanoma, ovarian and breast carcinoma cells. Clin Exp Immunol 95:148–155CrossRefPubMedPubMedCentral Obiri NI, Siegel JP, Varricchio F, Puri RK (1994) Expression of high-affinity IL-4 receptors on human melanoma, ovarian and breast carcinoma cells. Clin Exp Immunol 95:148–155CrossRefPubMedPubMedCentral
44.
Zurück zum Zitat Lan Q, Zheng T, Rothman N, Zhang Y, Wang SS, Shen M et al (2006) Cytokine polymorphisms in the Th1/Th2 pathway and susceptibility to non-Hodgkin lymphoma. Blood 107:4101–4108CrossRefPubMedPubMedCentral Lan Q, Zheng T, Rothman N, Zhang Y, Wang SS, Shen M et al (2006) Cytokine polymorphisms in the Th1/Th2 pathway and susceptibility to non-Hodgkin lymphoma. Blood 107:4101–4108CrossRefPubMedPubMedCentral
45.
Zurück zum Zitat Mainou-Fowler T, Proctor SJ, Taylor PR (2004) Interleukin 4 production by peripheral blood lymphocytes in patients with classical Hodgkin lymphoma. Leuk Res 28:159–166CrossRefPubMed Mainou-Fowler T, Proctor SJ, Taylor PR (2004) Interleukin 4 production by peripheral blood lymphocytes in patients with classical Hodgkin lymphoma. Leuk Res 28:159–166CrossRefPubMed
46.
Zurück zum Zitat Takeshi U, Sadar MD, Suzuki H, Akakura K, Sakamoto S, Shimbo M et al (2005) Interleukin-4 in patients with prostate cancer. Anticancer Res 25:4595–4598PubMed Takeshi U, Sadar MD, Suzuki H, Akakura K, Sakamoto S, Shimbo M et al (2005) Interleukin-4 in patients with prostate cancer. Anticancer Res 25:4595–4598PubMed
47.
Zurück zum Zitat Manchanda P, Sharma SC, Das SN (2006) Differential regulation of IL-2 and IL-4 in patients with tobacco-related oral squamous cell carcinoma. Oral Dis 12:455–462CrossRefPubMed Manchanda P, Sharma SC, Das SN (2006) Differential regulation of IL-2 and IL-4 in patients with tobacco-related oral squamous cell carcinoma. Oral Dis 12:455–462CrossRefPubMed
48.
Zurück zum Zitat Diakowska D, Markocka-Maczka K, Grabowski K, Lewandowski A (2006) Serum interleukin-12 and interleukin-18 levels in patients with oesophageal squamous cell carcinoma. Exp Oncol 28:319–322PubMed Diakowska D, Markocka-Maczka K, Grabowski K, Lewandowski A (2006) Serum interleukin-12 and interleukin-18 levels in patients with oesophageal squamous cell carcinoma. Exp Oncol 28:319–322PubMed
49.
Zurück zum Zitat Wen Z, Ouyang Q, Chen D, Su X (2003) [Interleukin 18 expression in colon cancer and adenoma]. Sichuan Da Xue Xue Bao Yi Xue Ban 34:262–264PubMed Wen Z, Ouyang Q, Chen D, Su X (2003) [Interleukin 18 expression in colon cancer and adenoma]. Sichuan Da Xue Xue Bao Yi Xue Ban 34:262–264PubMed
50.
Zurück zum Zitat Liu W, Han B, Sun B, Gao Y, Huang Y, Hu M (2012) Overexpression of interleukin-18 induces growth inhibition, apoptosis and gene expression changes in a human tongue squamous cell carcinoma cell line. J Int Med Res 40:537–544CrossRefPubMed Liu W, Han B, Sun B, Gao Y, Huang Y, Hu M (2012) Overexpression of interleukin-18 induces growth inhibition, apoptosis and gene expression changes in a human tongue squamous cell carcinoma cell line. J Int Med Res 40:537–544CrossRefPubMed
51.
Zurück zum Zitat Moreno SG, Sutton AJ, Thompson JR, Ades AE, Abrams KR, Cooper NJ (2012) A generalized weighting regression-derived meta-analysis estimator robust to small-study effects and heterogeneity. Stat Med 31:1407–1417CrossRefPubMed Moreno SG, Sutton AJ, Thompson JR, Ades AE, Abrams KR, Cooper NJ (2012) A generalized weighting regression-derived meta-analysis estimator robust to small-study effects and heterogeneity. Stat Med 31:1407–1417CrossRefPubMed
Metadaten
Titel
Significant association of the cytokine variants with head and neck cancer risk: evidence from meta-analysis
verfasst von
Ting-Ting Xiao
Xian Li
Ying Xu
Yong Li
Publikationsdatum
28.11.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
European Archives of Oto-Rhino-Laryngology / Ausgabe 2/2018
Print ISSN: 0937-4477
Elektronische ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-017-4820-4

Weitere Artikel der Ausgabe 2/2018

European Archives of Oto-Rhino-Laryngology 2/2018 Zur Ausgabe

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.